Fredun Pharmaceuticals Ltd

Mon 24/08/2026,15:31:33 | NSE : FREDUN

₹1431.10-3.50 (-0.24%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 1469.90

Previous Close

₹ 1434.60

Volume

17421

Mkt Cap ( ₹ Cr)

₹ 2044.32

High

₹ 1469.90

Low

₹ 1403.00

52 Week High

₹ 1590.00

52 Week Low

₹ 1400.00

Book Value Per Share

₹ 194.19

Dividend Yield

0.04

Face Value

₹ 10.00

What's Your Call?

Collective community sentiment on Fredun Pharmaceuticals Ltd

Your Vote -

Buy

40.00%

Hold

40.00%

Sell

20.00%

40.00%

5 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Fredun Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Fredun Pharma. Q1 net profit jumps 94.53% at Rs 13.17 cr

    19 Aug 2026, 8:20PM The company reported standalone net profit of Rs 13.17 crore for the quarter ended June 30, 2026 as compared to Rs 6.77 crore in the same period last

  • Fredun Pharma. - Intimation Regarding Permission To Trade And Admission Of Equity Shares To Dealings On The National Stock Ex

    17 Aug 2026, 7:24PM Intimation regarding permission to trade and admission of Equity Shares to dealing on the National Stock Exchange of India

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    17 Aug 2026, 4:21PM Transcript of the Earnings Conference call held on 13th August, 2026 for Q1 FY27.

  • Fredun Pharma. - Statement Of Deviation Or Variation For The Quarter Ended\r\nJune 30, 2026

    14 Aug 2026, 10:36PM Statement of Deviation or Variation For the Quarter Ended June 30, 2026.

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    14 Aug 2026, 10:27PM Monitoring Agency Report dated 14.08.2026

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    13 Aug 2026, 4:47PM Audio Recording Q1 FY27 'Earnings Conference Call' of Fredun\r\nPharmaceuticals Limited.

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    8 Aug 2026, 7:12PM Intimation of Earnings Conference Call for the quarter Q1 of FY27.

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    6 Aug 2026, 3:08PM Newspaper Advertisement of the Un-Audited Financial Results for Quarter ended 30th June, 2026

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    6 Aug 2026, 1:57PM Press Release issued by Fredun Pharmaceuticals Limited

  • Fredun Pharma. - Outcome Of The Board Meeting

    5 Aug 2026, 11:46AM Outcome of the Board Meeting

  • Fredun Pharma. - Board Meeting Outcome for Outcome Of The Board Meeting

    5 Aug 2026, 11:38AM In compliance to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Un-Audited Financial Results of

  • Fredun Pharma. - Board Meeting Intimation for Prior Intimation For The Board Meeting Of The Company To Be Held On Wednesday,

    30 Jul 2026, 6:15PM Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consid

  • Fredun Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended July 16, 2026

    17 Jul 2026, 7:41PM As of July 2026, 44.57% is owned by Indian Promoters and 55.43% by Public. <p align=justify> Top three Promoters holding highest number of shares of F

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Allotment

    17 Jul 2026, 1:06PM Allotment of Bonus Equity Shares.

  • Fredun Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    13 Jul 2026, 9:50PM As of June 2026, 44.57% is owned by Indian Promoters and 55.43% by Public. <p align=justify> Top three Promoters holding highest number of shares of F

  • Fredun Pharma. - Intimation Of Record Date Pursuant To Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirem

    10 Jul 2026, 5:02PM Intimation of Record Date pursuant to SEBI LODR Regulations, 2015 for Issue of Bonus Equity Shares.

  • Fredun Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Jul 2026, 6:20PM Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018

  • Fredun Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Jun 2026, 6:00PM Scrutinizer's Report for 39th Annual General Meeting.

  • Fredun Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Jun 2026, 6:00PM Scrutinizer's Report for 39th Annual General Meeting.

  • Fredun Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Jun 2026, 6:00PM Scrutinizer's Report for 39th Annual General Meeting.

  • Fredun Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Jun 2026, 6:00PM Scrutinizer's Report for 39th Annual General Meeting.

  • Fredun Pharma. - Shareholder Meeting / Postal Ballot-Outcome of AGM

    30 Jun 2026, 5:55PM Outcome of 39th Annual General Meeting

  • Fredun Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Jun 2026, 6:00PM Scrutinizer's Report for 39th Annual General Meeting.

  • Fredun Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Jun 2026, 6:00PM Scrutinizer's Report for 39th Annual General Meeting.

  • Fredun Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Jun 2026, 6:00PM Scrutinizer's Report for 39th Annual General Meeting.

  • Fredun Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Jun 2026, 6:00PM Scrutinizer's Report for 39th Annual General Meeting.

  • Fredun Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Jun 2026, 6:00PM Scrutinizer's Report for 39th Annual General Meeting.

  • Fredun Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Jun 2026, 6:00PM Scrutinizer's Report for 39th Annual General Meeting.

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    12 Jun 2026, 7:29PM Transcript of the Earnings conference call held on 10th June 2026 for Q4 FY26.

  • Fredun Pharma. has declared 7% Final dividend for the financial year March 2026

    11 Jun 2026, 7:04AM Fredun Pharmaceuticals Ltd. on Monday, 25 May 2026, has announced Final dividend of 7 percent on Equity Share, to its shareholders holding shares on t

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    10 Jun 2026, 7:03PM Audio Recording of the Q4 and year ended for the FY26 'Earnings Conference Call'\r\n\r\n\r\n

  • Fredun Pharma. - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 20

    8 Jun 2026, 7:57PM Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (\SEBI Listing Regulations\)

  • Fredun Pharma. - Intimation Of Record Date For The Purpose Of Final Dividend For The Financial Year 2025-26

    8 Jun 2026, 7:37PM Intimation of Record Date for the purpose of Final Dividend for the Financial Year 2025-26

  • Fredun Pharma. - Notice Of Book Closure For The Purpose Of 39Th Annual General Meeting (AGM).

    8 Jun 2026, 7:33PM Notice of Book Closure for the purpose of 39th Annual General Meeting (AGM)

  • Fredun Pharma. - Notice Convening 39Th Annual General Meeting ('AGM') Of Fredun Pharmaceuticals Limited

    8 Jun 2026, 4:57PM Notice convening 39th Annual General Meeting (\AGM\) of Fredun Pharmaceuticals Limited

  • Fredun Pharma. - Reg. 34 (1) Annual Report.

    8 Jun 2026, 4:54PM Annual Report of Fredun Pharmaceuticals Limited for the Financial Year 2025-2026 including the Notice of the 39th Annual General Meeting of the Compan

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    8 Jun 2026, 11:28AM Revised intimation of Earnings Conference Call for the quarter Q4 of FY26.

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    6 Jun 2026, 5:42PM Intimation of Earnings Conference Call for the quarter Q4 of FY 2026.

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    6 Jun 2026, 3:16PM Intimation of Earning Conference call for the quarter Q4 of FY 2026.

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Change in Management

    25 May 2026, 10:06PM Re-appointment of Internal Auditor and Cost Auditor of the Company for the FY 2026-2027.

  • Fredun Pharma. - Revised Outcome.

    25 May 2026, 9:53PM Revised Outcome.

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    25 May 2026, 5:55PM Press Release titled Fredun Pharmaceuticals Announces 2:1 Bonus Issue, Signaling Strong Growth Confidence

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    25 May 2026, 5:50PM Press Release title Fredun Pharmaceuticals Delivers Robust FY 26 Performance; Revenue Jumps 40%, EBITDA Surges 72% and Profit Rises ~60% YoY

  • Fredun Pharma. Q4 net profit jumps 56.58% at Rs 11.07 cr

    25 May 2026, 3:30PM The company reported standalone net profit of Rs 11.07 crore for the quarter ended March 31, 2026 as compared to Rs 7.07 crore in the same period last

  • Fredun Pharma. - Audited Results For The Quarter And Year Ended On 31St March, 2026.

    25 May 2026, 3:07PM Audited Results for the quarter and year ended on 31st March, 2026.

  • Fredun Pharma. - Board Meeting Outcome for Outcome Of Board Meeting Held On 25Th May, 2026

    25 May 2026, 2:58PM Outcome of Board Meeting held on 25th May, 2026
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Fredun Pharmaceuticals Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 500.7423 307.8076 226.9811 182.9008 120.825
Liabilities 500.7423 307.8076 226.9811 182.9008 120.825
Equity 5.4727 4.7217 4.6992 4.5323 4.4326
Gross Profit 91.1373 52.6457 37.9823 27.7774 13.7953
Net Profit 33.2069 20.8075 15.6234 10.8066 6.3353
Cash From Operating Activities 16.438 -28.8833 -0.4387 -14.4088 -2.3802
NPM(%) 5.22 4.58 4.48 3.93 2.82
Revenue 635.4657 453.8174 348.1562 274.6756 224.4595
Expenses 544.3284 401.1717 310.1739 246.8982 210.6642
ROE(%) 11.97 7.5 5.63 3.89 2.28

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Fredun Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 888.70 2.84 22.48 819.07 -26.19 0.56
Lotus Eye Hospital and Institute Ltd 115.50 -0.09 1650.00 2984.58 0.39 0.00
Vaishali Pharma Ltd 8.12 1.63 25.37 18723.27 15.42 0.00
Astec Lifesciences Ltd 592.70 -1.52 0.00 3197.82 -363.14 0.00

Company Info

Fredun Pharmaceuticals Ltd is a Public Company incorporated on 08 June 1987. It is classified as Indian Non-Government Company and is registered at Registrar of Companies, Mumbai. It is involved in Manufacture of other chemical products. FREDUN as a group is dedicated to improving lives. Our aim is not profitability, it is effective efficiency. We want our products and services to promote growth and save costs for our customers. 2021-The Company has received a Prestigious and a well-recognized award in the Healthcare Sector 'India's Most Admirable Brand' presented to the Company.2025-The Company acquires Wagr.ai to Enter India & Pet Tech Market-The Company as a leading provider of pharmaceuticals and innovative healthcare solutions for human and veterinary applications-The newly introduced product range, including offerings under MCHC, Functional, Therapeutic, and Grooming categories, has already gained significant praise for its quality and effectiveness.-Fredun Pharma's Freossi Division Marks Its Entry into Sri Lanka with a Suite of Premium Quality Petcare Products.

Fredun Pharmaceuticals Ltd is a Public Company incorporated on 08 June 1987. It is classified as Indian Non-Government Company and is registered at Registrar of Companies, Mumbai. It is involved in Manufacture of other chemical products. FREDUN as a group is dedicated to improving lives. Our aim is not profitability, it is effective efficiency. We want our products and services to promote growth and save costs for our customers. 2021-The Company has received a Prestigious and a well-recognized award in the Healthcare Sector 'India's Most Admirable Brand' presented to the Company.2025-The Company acquires Wagr.ai to Enter India & Pet Tech Market-The Company as a leading provider of pharmaceuticals and innovative healthcare solutions for human and veterinary applications-The newly introduced product range, including offerings under MCHC, Functional, Therapeutic, and Grooming categories, has already gained significant praise for its quality and effectiveness.-Fredun Pharma's Freossi Division Marks Its Entry into Sri Lanka with a Suite of Premium Quality Petcare Products.

Parent Organisation

Fredun Pharmaceuticals Ltd.

Founded

08/06/1987

Managing Director

Dr.(Mrs.)Daulat N Medhora

NSE Symbol

FREDUNEQ

FAQ